Contineum Therapeutics (CTNM) Return on Capital Employed (2024 - 2026)
Contineum Therapeutics' (CTNM) quarterly Return on Capital Employed came in at 25.48% in Q1 2026, up 456.0% year-on-year from 4.58% in Q1 2025, and up 16.13% quarter-over-quarter from 30.38% in Q4 2025.
Contineum Therapeutics (CTNM) Return on Capital Employed (2024 - 2026) Analysis & Trends
Contineum Therapeutics' Return on Capital Employed history runs 3 years deep, the most recent figure standing at 25.48% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 456.0% year-over-year to 25.48% in Q1 2026; TTM through Mar 2026 was 25.48%, a 456.0% increase from a year earlier, with the FY2025 full-year figure at 28.96%, up 252.0% from the prior year.
- Return on Capital Employed grew to 25.48% in Q1 2026 per CTNM's latest filing, from 30.38% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 9.33% in Q1 2024 and bottomed at 37.67% in Q3 2025.
- The 3-year median for Return on Capital Employed is 25.48% (2026), against an average of 24.28%.
- Across the five-year window, Return on Capital Employed tumbled 3937 bps in 2025 and jumped 456 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 24.89% in 2024, then slipped by 22 bps to 30.38% in 2025, then advanced by 16 bps to 25.48% in 2026.
- Per Business Quant, the three latest CTNM Return on Capital Employed figures stand at 25.48% (Q1 2026), 30.38% (Q4 2025), and 37.67% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | -25.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.48% |
| Dec 31, 2025 | -30.38% |
| Sep 30, 2025 | -37.67% |
| Jun 30, 2025 | -36.01% |
| Mar 31, 2025 | -30.05% |
| Dec 31, 2024 | -24.89% |
| Sep 30, 2024 | -20.44% |
| Jun 30, 2024 | -22.89% |
| Mar 31, 2024 | 9.33% |